The current valuation score of Compugen Ltd is 7.81, ranking 198 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is 5.52, which is 1551.48% below the recent high of 91.17 and 463.34% above the recent low of -20.06.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.